Analystreport

Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) was given a new $7.00 price target on by analysts at Maxim Group. They now have a "buy" rating on the stock.

Sonoma Pharmaceuticals, Inc.  (SNOA) 
Last sonoma pharmaceuticals, inc. earnings: 2/14 05:13 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.sonomapharma.com